A detailed history of Smartleaf Asset Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 880 shares of REGN stock, worth $626,912. This represents 0.11% of its overall portfolio holdings.

Number of Shares
880
Previous 667 31.93%
Holding current value
$626,912
Previous $701 Million 31.0%
% of portfolio
0.11%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1024.09 - $1201.76 $218,131 - $255,974
213 Added 31.93%
880 $918 Million
Q2 2024

Aug 13, 2024

BUY
$883.2 - $1071.19 $164,275 - $199,241
186 Added 38.67%
667 $701 Million
Q1 2024

Oct 07, 2024

SELL
$902.69 - $993.35 $167,900 - $184,763
-186 Reduced 27.89%
481 $465 Million
Q1 2024

May 02, 2024

BUY
$902.69 - $993.35 $195,883 - $215,556
217 Added 82.2%
481 $266 Million
Q4 2023

Feb 12, 2024

BUY
$775.18 - $881.7 $204,647 - $232,768
264 New
264 $233 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.